Works matching DE "GOLIMUMAB"


Results: 323
    1
    2
    3
    4

    Factors associated with long-term retention of treatment with golimumab in rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis: an analysis of the Spanish BIOBADASER registry.

    Published in:
    Clinical Rheumatology, 2021, v. 40, n. 10, p. 3979, doi. 10.1007/s10067-021-05742-3
    By:
    • Pombo-Suarez, Manuel;
    • Sanchez-Piedra, Carlos;
    • Garcia-Magallón, Blanca;
    • Pérez-Gómez, Ana;
    • Manrique-Arija, Sara;
    • Martín-Doménech, Raquel;
    • Colazo, María;
    • Campos, Cristina;
    • Campos, José;
    • del Pino-Montes, Javier;
    • Arteaga, Maria J.;
    • Cea-Calvo, Luis;
    • Díaz-González, Federico;
    • Gómez-Reino, Juan J.
    Publication type:
    Article
    5
    6
    7

    Long-term safety and effectiveness of tocilizumab in patients with rheumatoid arthritis and inadequate responses to csDMARDs and/or TNF inhibitors: an open-label study close to clinical practice.

    Published in:
    Clinical Rheumatology, 2019, v. 38, n. 9, p. 2411, doi. 10.1007/s10067-019-04535-z
    By:
    • Bykerk, Vivian P.;
    • Östör, Andrew J. K.;
    • Alvaro-Gracia, José;
    • Pavelka, Karel;
    • Román Ivorra, José Andrés;
    • Nurmohamed, Michael T.;
    • Luder, Yves;
    • Sidiropoulos, Paris N. M.;
    • Devenport, Jenny;
    • Sibilia, Jean
    Publication type:
    Article
    8
    9
    11

    Treatment patterns among patients with rheumatic disease (rheumatoid arthritis (RA), ankylosing spondylitis (AS), psoriatic arthritis (PsA) and undifferentiated arthritis (UnA)) treated with subcutaneous TNF inhibitors.

    Published in:
    Clinical Rheumatology, 2018, v. 37, n. 6, p. 1617, doi. 10.1007/s10067-018-4105-3
    By:
    • Tymms, Kathleen;
    • Littlejohn, Geoff;
    • Griffiths, Hedley;
    • de Jager, Julien;
    • Bird, Paul;
    • Joshua, Fred;
    • Nash, Peter;
    • Handel, Malcolm;
    • McManus, Hamish;
    • Butcher, Belinda E.;
    • Youssef, Peter
    Publication type:
    Article
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22

    Clinical efficacy, radiographic, and safety results of golimumab monotherapy in Japanese patients with active rheumatoid arthritis despite prior therapy with disease-modifying antirheumatic drugs: Final results of the GO-MONO trial through week 120.

    Published in:
    Modern Rheumatology, 2018, v. 28, n. 5, p. 770, doi. 10.1080/14397595.2017.1404731
    By:
    • Tsutomu Takeuchi;
    • Masayoshi Harigai;
    • Yoshiya Tanaka;
    • Hisashi Yamanaka;
    • Naoki Ishiguro;
    • Kazuhiko Yamamoto;
    • Nobuyuki Miyasaka;
    • Takao Koike;
    • Yoshifumi Ukyo;
    • Yutaka Ishii;
    • Toru Yoshinari;
    • Daniel Baker
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33

    Evolution of Rheumatoid-Arthritis-Associated Interstitial Lung Disease in Patients Treated with JAK Inhibitors: A Retrospective Exploratory Study.

    Published in:
    Journal of Clinical Medicine, 2023, v. 12, n. 3, p. 957, doi. 10.3390/jcm12030957
    By:
    • Venerito, Vincenzo;
    • Manfredi, Andreina;
    • Carletto, Antonio;
    • Gentileschi, Stefano;
    • Atzeni, Fabiola;
    • Guiducci, Serena;
    • Lavista, Marlea;
    • La Corte, Laura;
    • Pedrollo, Elisa;
    • Scardapane, Arnaldo;
    • Tomassini, Caterina;
    • Frediani, Bruno;
    • Salvarani, Carlo;
    • Iannone, Florenzo;
    • Sebastiani, Marco
    Publication type:
    Article
    34

    Serum IL-13 Predicts Response to Golimumab in Bio-Naïve Ulcerative Colitis.

    Published in:
    Journal of Clinical Medicine, 2022, v. 11, n. 17, p. 4952, doi. 10.3390/jcm11174952
    By:
    • Kinoshita, Naohiko;
    • Kakimoto, Kazuki;
    • Shimizu, Hikaru;
    • Nishida, Koji;
    • Numa, Keijiro;
    • Kawasaki, Yuka;
    • Tawa, Hideki;
    • Nakazawa, Kei;
    • Koshiba, Ryoji;
    • Hirata, Yuki;
    • Sakiyama, Naokuni;
    • Koubayashi, Eiko;
    • Takeuchi, Toshihisa;
    • Miyazaki, Takako;
    • Higuchi, Kazuhide;
    • Nakamura, Shiro;
    • Nishikawa, Hiroki
    Publication type:
    Article
    35

    Effectiveness of Golimumab as Second Anti-TNFα Drug in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondyloarthritis in Italy: GO-BEYOND, a Prospective Real-World Observational Study.

    Published in:
    Journal of Clinical Medicine, 2022, v. 11, n. 14, p. 4178, doi. 10.3390/jcm11144178
    By:
    • D'Angelo, Salvatore;
    • Tirri, Enrico;
    • Giardino, Angela Maria;
    • Mattucci-Cerinic, Marco;
    • Dagna, Lorenzo;
    • Santo, Leonardo;
    • Ciccia, Francesco;
    • Frediani, Bruno;
    • Govoni, Marcello;
    • Bobbio Pallavicini, Francesca;
    • Grembiale, Rosa Daniela;
    • Delle Sedie, Andrea;
    • Mulè, Rita;
    • Cantatore, Francesco Paolo;
    • Foti, Rosario;
    • Gremese, Elisa;
    • Conigliaro, Paola;
    • Salaffi, Fausto;
    • Viapiana, Ombretta;
    • Cauli, Alberto
    Publication type:
    Article
    36

    Golimumab for Rheumatoid Arthritis.

    Published in:
    Journal of Clinical Medicine, 2019, p. 387, doi. 10.3390/jcm8030387
    By:
    • Pelechas, Eleftherios;
    • Voulgari, Paraskevi V.;
    • Drosos, Alexandros A.
    Publication type:
    Article
    37
    38
    39
    40
    41
    42
    43
    44

    Long-term Treatment with Golimumab for Severe Uveitis.

    Published in:
    Ocular Immunology & Inflammation, 2014, v. 22, n. 2, p. 90, doi. 10.3109/09273948.2013.844265
    By:
    • Miserocchi, Elisabetta;
    • Modorati, Giulio;
    • Pontikaki, Irene;
    • Meroni, Pier Luigi;
    • Gerloni, Valeria
    Publication type:
    Article
    45
    46
    47
    48
    49
    50